System Transmission

Top Signal

100#1 JOB

Activity

2168Ripe

+909 today

System

Live1m

Terminal Asset View

stockNASDAQ

ACOG

$5.75-1.71%

Alpha Cognition Inc

Neutral

Official Site

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

41Neutral

Live Analysis Active

Company Mission

Alpha Cognition creates oral medications designed to treat symptoms of Alzheimer's disease. These drugs are being tested in clinical trials with patients who have memory problems. The company makes money by advancing these drugs through development stages and hopes to eventually sell them to healthcare providers if approved.

ACO

Industry Context

Alpha Cognition operates in the biotechnology sector, which focuses on developing treatments for diseases. This industry is highly research-driven, with companies spending years testing drugs before they can be sold. Success depends on clinical trial results and regulatory approvals from agencies like the FDA.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

85Matrix

Market Momentum

51.0— Holding Steady

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.3x— Normal Volume

Today's Change

-1.71%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing ACOG across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 05:42 AM UTC

As-of 03-15-2026 05:26 UTC

Develops drugs for Alzheimer's disease and makes money by selling treatments to patients through pharmacies and healthcare providers.

Price below key moving averages, suggesting a downtrend caution as sellers have dominated recent action showing consolidation pattern.

Technical squeeze detected near recent lows, indicating breakout potential if buyers step in to challenge resistance, suggesting challenge resistance.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...